Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

BGI-Shenzhen Closes $118 Million Acquisition of Complete Genomics

publication date: Mar 19, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BGI-Shenzhen, the world’s largest gene sequencing company, closed its $118 million acquisition of Complete Genomics. Complete Genomics is a Silicon Valley company that specializes in whole human genome sequencing. BGI purchased all of Complete's outstanding common shares at $3.15 each, and it will operate Complete as a wholly-owned subsidiary. Dr. Clifford Reid will remain its CEO. Note: ChinaBio® recently interviewed Jun Wang, PhD, CEO of BGI, who talked about the Complete acquisition and other matters. The interview is available here. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners